Review in The Journal of physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Dmitry TerentyevDorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0002-9530-7384
Alexey V GlukhovCellular and Molecular Arrhythmia Research Program, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin, Madison, USA.ORCID https://orcid.org/0000-0003-2076-9688
Vladimir BogdanovDorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.ORCID https://orcid.org/0000-0001-9287-5303
Aleksei S AverinCellular and Molecular Arrhythmia Research Program, Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin-Madison, Wisconsin, Madison, USA.
Roland VeressDorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
Bum-Rak ChoiCardiovascular Research Center, Rhode Island Hospital, Department of Medicine, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.ORCID https://orcid.org/0000-0001-7319-3219
Andriy E BelevychDorothy M. Davis Heart and Lung Research Institute, Department of Physiology and Cell Biology, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
Funding
Functional Microdomains in the Heart's Pacemaker: A New Dimension of Cardiac RemodelingR01HL141214 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI Alexey V Glukhov · 2018 to 2026
$3.8M
The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesisR01HL166604 · NHLBI · OHIO STATE UNIVERSITY · PI Dmitry A Terentyev · 2023 to 2026
$2.8M
Cardiac ryanodine receptor and oxidative stressR00HL155492 · NHLBI · UNIVERSITY OF ARIZONA · PI HAMILTON, SHANNA · 2023 to 2025
$747k
Defining the role of KCNN1 in atrial arrhythmiasR03TR004471 · NCATS · OHIO STATE UNIVERSITY · PI TERENTYEV, DMITRY A · 2023 to 2023
$158k
American Heart Association 24TPA1293486Harold S. Geneen Charitable Trust Awards Program for Coronary Heart Disease Research 24SHNCATS NIH HHS R03 TR004471NCATS NIH HHS R03TR004471NHLBI NIH HHS R00 HL155492NHLBI NIH HHS R00HL155492NHLBI NIH HHS R01 HL141214NHLBI NIH HHS R01HL141214NHLBI NIH HHS R01 HL166604NHLBI NIH HHS R01HL166604The Ohio State University College of Medicine Office of Research Dean's Strategic Bridge Funding Program
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.